Results 121 to 130 of about 69,766 (243)

Prevalence, Severity, and Clinical Course of Atopic Dermatitis in Japan: A Web‐Based Questionnaire Survey

The Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis is a chronic inflammatory skin disease that commonly begins in childhood but exhibits heterogeneous long‐term clinical courses. We conducted a cross‐sectional questionnaire survey among dermatologists to evaluate age‐specific prevalence, remission proportion, severity, and disease course of atopic dermatitis in Japan.
Takeshi Nakahara, Sakae Kaneko, Norito Katoh, Maki Ozawa, Hiroyuki Kanoh, Yutaka Hatano, Yuko Watanabe, Yasuyuki Sumikawa, Daisuke Onozuka, Akio Tanaka, Yoko Kataoka, Hiroyuki Murota   +11 more
wiley   +1 more source

Atopic Dermatitis in Children: Differential Diagnosis and Mimickers. [PDF]

Children (Basel)
Türe Avcı B, Çetinarslan T, Türel Ermertcan A, Fölster-Holst R.   +3 more
europepmc   +1 more source

Extended‐Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real‐World Retrospective Study

The Journal of Dermatology, EarlyView.
ABSTRACT This retrospective study evaluated the clinical courses and treatment patterns of 81 patients with atopic dermatitis (AD) treated with dupilumab at Hiroshima University Hospital. Patients were categorized into six groups based on their clinical outcomes, including those who continued treatment, achieved remission and discontinued, or ...
Ryo Saito, Wataru Sasaki, Haruka Watanabe, Momoka Hashimoto, Rina Kamigaki, Kento Nagiri, Akio Tanaka   +6 more
wiley   +1 more source

Use of abrocitinib in severe atopic dermatitis. [PDF]

Rev Assoc Med Bras (1992)
Cruz MFMND, Criado GJ, Ortrolani TA, Martins MDS, Dinato SLME, Silvinato A, Bernardo WM.   +6 more
europepmc   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Peter Barclay, Melanie Wong, Li‐Chuen Wong   +7 more
wiley   +1 more source

The Pathogenesis of Atopic Dermatitis-Trends for the Future. [PDF]

J Dermatol
Katoh N.
europepmc   +1 more source

Correction to “Perceptions of a Group of Experts on the Integration of Artificial Intelligence in the Management of Atopic Dermatitis”

JEADV Clinical Practice, EarlyView.
wiley   +1 more source

Culturally Safe and Decentralised Care: Patient Experiences of a Dermatology Clinic Embedded in an Aboriginal and Torres Strait Islander Primary Health Care Service

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background Skin disease is a major cause of morbidity in Australia and a leading reason for primary care visits. Aboriginal and Torres Strait Islander peoples experience a disproportionate burden of skin conditions but face barriers to accessing culturally safe specialist services.
Nikhil Dwivedi, Nicholas Van Rooij, Geoffrey Spurling, Claudette (Sissy) Tyson, Sonya Egert, Erin McMeniman, Noel Hayman   +6 more
wiley   +1 more source

Knowledge, Attitudes, and Practices Towards Atopic Dermatitis Among Parents of Children with Atopic Dermatitis: A Cross-Sectional Study. [PDF]

J Asthma Allergy
Zheng H, Shen C, Xu D, Ji C, Feng J, Zhou S, Li Y.   +6 more
europepmc   +1 more source

Sequence of Immunological Events During IgE‐Mediated Allergic Reactions to Food

Allergy, EarlyView.
ABSTRACT Food allergies (FA) represent a significant global health burden. Upon allergen re‐exposure, allergic patients exhibit a sequence of symptoms that vary in terms of affected organ systems, severity, time of onset and allergen reactivity thresholds.
N. A. Nagy, D. Schnoegl, V. Houghton, L. O'Mahony, A. F. Santos, E. F. Knol, A. Kuehn, T. Eiwegger   +7 more
wiley   +1 more source